Key facts
- This page summarizes Christopher M. Smith's Form 4 filing for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Feb 2025, 19:22.
Christopher M. Smith - 30 Jan 2025 Form 4 Insider Report for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
- Reporting relationship
- Director
- Issuer ticker
- PACB
- Reported as of
- 30 Jan 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Feb 2025, 19:22:21 UTC
- Prior SEC filing
- 19 Aug 2024
- Next SEC filing
- 25 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michele Farmer, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher M. Smith filed Form 4 for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) on 03 Feb 2025.
Change
- Previous filing in this sequence was filed on 19 Aug 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PACB
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +54,099
- Change %
- Price
- $0.000000
- Shares after
- 54,099
- Date
- 30 Jan 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PACB
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +72,901
- Change %
- Price
- $0.000000
- Shares after
- 72,901
- Date
- 30 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 72,901
- Exercise price
- $1.60
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Mr. Smith was elected to the Board of Directors on January 30, 2025. Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on January 30th of each of 2026, 2027, and 2028, provided such Reporting Person continues to serve as a director through the applicable vesting dates.
Footnote F2
One-third of the shares subject to the option will vest on January 30, 2026, which is the one year anniversary of Mr. Smith joining the Board, and the remainder will vest in equal monthly installments thereafter for 24 months on the same date of the month as his initial start date, provided he continues to serve as a director through each vesting date.